EP
Epigenomics AG
EPGNF · OTC
$1.12 +0.00% (+$0.00)
Market Cap 860.4K €
P/E Ratio -
Div. Yield -
ROE -
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
2/9Valuation
66 /100
Fair P/S 2.54x
PEG N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 26.14%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 1,231.19%
Gross margin 83.22%
FCF margin 1,684.42%
Quality
0 /100
Poor Asset turnover 0.03x
ROIC 33.23%
ROA 34.75%
Debt
100 /100
Low Net debt/EBITDA -2.71x
Current ratio 9.03x
Debt/Assets N/A
Stability
26 /100
Unstable EPS volatility 184.11%
Beta 0.87x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o EPGNF
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Jason Wouhra
Employees
3
Headquarters
Heidelberg